Composed of experts from academia and industry, the SSAB will closely work with Biofortis’ management team. The SSAB’ missions will be to analyze the current scientific paradigm in the microbiome science, drive and enhance surveillance for partnership & collaborations, predict both macro and microeconomic evolutions of the microbiome market and contribute to the development of Biofortis’ strategy and to the evolution of its services in clinical studies and microbiota.
Biofortis’ Scientific & Strategy Advisory Board
Internal members

Françoise Le Vacon
CSO

Benoit Fouchaq
CEO

Sébastien Leuillet
CTO and Bioinformatics Manager
External members

Murielle Cazaubiel
Chief Medical Officer in VALBIOTIS, an expert in clinical research in nutrition

Etienne Casal
Consultant

Jeroen Raes
Associate Professor in Microbiota Bioinformatics & Systems Biology at KU Leuven and VIB group leader

Isabelle De Crémoux
CEO of Seventure Partners

Hervé Haffagard
Chief Executive Officer of Maat Pharma and expert in fecal microbiota transplantation